Упрощенная HTML-версия
143
145.
Systemic cytokine levels in community- acquired pneumonia and their
association with disease severity / G. Antunes, S. A. Evans, J.L. Lordan, A.J. Frew //
Eur. Respir. J. – 2002. – Vol. 20. – Р. 990-995.
146.
The CURB (confusion, urea, respiratory rate and blood pressure) criteria
in community-acquired pneumonia (CAP) in hospitalized elderly patients aged 65
years and over: a prospective observational cohort study / P.K.
et al.] //
– 2005. – Vol. 34, № 1. – P. 75-77.
147.
The influence of age and gender on the population-based incidence of
community-acquired pneumonia caused by different microbial pathogens / F.
et al.] //
– 2006. – Vol. 53, № 3. – P. 166-174.
148.
Trends in hospitalizations for pneumonia among persons aged 65 years
or older in the United States, 1988-2002 / A.M.
et al.] //
– 2005. – Vol.
294, № 21. – P. 2712-2719.
149.
Validation of predictive rules and indices of severity for community
acquired pneumonia / S.
[et al.] //
– 2004. – Vol. 59, № 5. – P. 421-
427.
150.
Weyers C.M. Nonresolving pneumonia / C.M. Weyers, K.V. Leeper //
Clin. Chest Med. – 2005. - Vol. 26, № 1. – P. 143-158.
151.
Woodhead M. Community-acquired pneumonia in the elderly people:
addition of erythromycin is not currently justified / M. Woodhead // BMJ. – 1998. -
Vol. 317. - P. 1594.
152.
Wort S.S. Community-acquired pneumonia in elderly people / S.S. Wort,
T.R. Rogers // BMJ. – 1998. – Vol. 316. – P. 1690.